|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
396,340,000 |
Market
Cap: |
227.89(B) |
Last
Volume: |
1,171,942 |
Avg
Vol: |
1,560,718 |
52
Week Range: |
$431.41 - $599.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 108 |
Guru Rank Value : 8.2 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile Thermo Fisher Scientific is engaged in serving science. Co.'s segments include: Life Sciences Solutions, which provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, which provides instruments, consumables, software and services that are used for a range of applications in the laboratory, on the production line and in the field; and Specialty Diagnostics, which provides diagnostic test kits, reagents, culture media, instruments and associated products for customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
4 |
4 |
Total Buy Value |
$0 |
$0 |
$2,105 |
$2,105 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
106,622 |
138,222 |
233,522 |
543,986 |
Total Sell Value |
$61,552,361 |
$75,849,157 |
$128,254,192 |
$299,949,482 |
Total People Sold |
4 |
4 |
6 |
8 |
Total Sell Transactions |
12 |
16 |
27 |
63 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mullen James C |
Director |
|
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
392 |
2,489 |
|
- |
|
Chandy Ruby R |
Director |
|
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
392 |
2,060 |
|
- |
|
Jacks Tyler |
Director |
|
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
392 |
8,059 |
|
- |
|
Sperling Scott M |
Director |
|
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
392 |
72,462 |
|
- |
|
Chai Nelson |
Director |
|
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
392 |
13,909 |
|
- |
|
Keith R. Alexandra |
Director |
|
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
392 |
1,199 |
|
- |
|
Sorensen Lars Rebien |
Director |
|
2023-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
392 |
9,351 |
|
- |
|
Weisler Dion J |
Director |
|
2023-05-18 |
4 |
D |
$523.54 |
$27,748 |
D/D |
(53) |
3,844 |
|
- |
|
Sorensen Lars Rebien |
Director |
|
2023-05-18 |
4 |
D |
$523.54 |
$58,113 |
D/D |
(111) |
8,959 |
|
- |
|
Holmes Joseph R. |
VP & Chief Accounting Officer |
|
2023-05-12 |
4 |
D |
$524.65 |
$2,623 |
D/D |
(5) |
1,575 |
|
- |
|
Casper Marc N |
Chairman & CEO |
|
2023-05-09 |
4 |
AS |
$530.98 |
$855,710 |
D/D |
(1,600) |
141,330 |
|
-5% |
|
Casper Marc N |
Chairman & CEO |
|
2023-05-09 |
4 |
OE |
$157.68 |
$252,288 |
D/D |
1,600 |
142,930 |
|
- |
|
Casper Marc N |
Chairman & CEO |
|
2023-05-08 |
4 |
AS |
$541.85 |
$5,444,003 |
D/D |
(10,000) |
141,330 |
|
-5% |
|
Casper Marc N |
Chairman & CEO |
|
2023-05-08 |
4 |
OE |
$157.68 |
$1,576,800 |
D/D |
10,000 |
151,330 |
|
- |
|
Casper Marc N |
Chairman & CEO |
|
2023-05-05 |
4 |
AS |
$542.50 |
$5,452,236 |
D/D |
(10,000) |
141,330 |
|
-6% |
|
Casper Marc N |
Chairman & CEO |
|
2023-05-05 |
4 |
OE |
$157.68 |
$1,576,800 |
D/D |
10,000 |
151,330 |
|
- |
|
Pettiti Gianluca |
Executive Vice President |
|
2023-05-05 |
4 |
D |
$546.38 |
$64,473 |
D/D |
(118) |
18,601 |
|
- |
|
Casper Marc N |
Chairman & CEO |
|
2023-05-04 |
4 |
AS |
$543.65 |
$5,469,779 |
D/D |
(10,000) |
141,330 |
|
-6% |
|
Casper Marc N |
Chairman & CEO |
|
2023-05-04 |
4 |
OE |
$157.68 |
$1,576,800 |
D/D |
10,000 |
151,330 |
|
- |
|
Lagarde Michel |
Executive Vice President & COO |
|
2023-03-05 |
4 |
D |
$559.44 |
$73,287 |
D/D |
(131) |
19,184 |
|
- |
|
Pettiti Gianluca |
Executive Vice President |
|
2023-03-05 |
4 |
D |
$559.44 |
$36,923 |
D/D |
(66) |
18,719 |
|
- |
|
Pettiti Gianluca |
Executive Vice President |
|
2023-02-28 |
4 |
D |
$541.76 |
$420,948 |
D/D |
(777) |
18,785 |
|
- |
|
Boxer Michael A |
SVP and General Counsel |
|
2023-02-28 |
4 |
D |
$541.76 |
$120,812 |
D/D |
(223) |
13,553 |
|
- |
|
Casper Marc N |
Chairman & CEO |
|
2023-02-28 |
4 |
D |
$541.76 |
$1,445,957 |
D/D |
(2,669) |
141,330 |
|
- |
|
Lagarde Michel |
Executive Vice President & COO |
|
2023-02-28 |
4 |
D |
$541.76 |
$552,053 |
D/D |
(1,019) |
19,315 |
|
- |
|
2025 Records found
|
|
Page 5 of 81 |
|
|